Call for proposals for the funding of NBIA research projects

Call for proposals for the funding of NBIA research projects

The NBIA patient organizations AISNAF (Italy), Hoffnungsbaum e.V.(Germany) and NBIA Disorders Association (USA) announce a joint funding initiative to award research grants for the study of the following two NBIA variants:

  1. Beta-propeller protein associated neurodegeneration (BPAN - gene WDR45):
    Funding of up to €65,000 is available for an 18-month research project on BPAN.
  2. Mitochondrial membrane protein-associated neurodegeneration (MPAN gene c19orf12):
    Funding of up to € 90,000 is available for a 2-year research project on MPAN.  

Deadline for the submission of proposals: May 13, 2019

As manager of this international joint initiative, the Italian patient organization AISNAF is currently accepting applications with project proposals. The research projects are intended to pave the way for new treatment options for the aforementioned NBIA diseases.

Further information and the funding application can be found here:
https://www.aisnaf.org/bandi-per-progetti-calls-for-proposals/

The participation of Hoffnungsbaum e.V. in this funding initiative was made possible by the "Milly's Mission" fundraising campaigns of the Nielbock family (www.millys-mission.de) and "Help Maya" https://helft-maya.de/ from the Matthiesen family.
On behalf of all those affected by BPAN and MPAN, we would like to thank the two families and all donors for their commitment, which Hoffnungsbaum e.V. which has enabled us to provide a total of €46,000 for BPAN and MPAN research projects.

News from Maya and the MPAN fundraising campaign

News from Maya and the MPAN fundraising campaign

In December, we had the Fundraising campaign by the Matthiesen family for the benefit of MPAN research. Maya herself actively supports this crowdfunding campaign, which was launched by her parents shortly after her diagnosis.

Together with her older brother, she produced this touching video. In it, she thanks the people who have donated at Christmas - also on behalf of and with numerous pictures of many other MPAN sufferers around the world. These donations are intended to help uncover the exact disease mechanisms that lead to the illness and to find therapies for MPAN that can halt the progression of the disease. Like all NBIA diseases, MPAN is currently incurable.

Since the end of November, more than 10,000 euros have been credited to the donation account of Hoffnungsbaum for the benefit of MPAN-Forschung e.V. in order to get closer to this goal. The start has been made...

Many thanks also from us at the Hoffnungsbaum head office to all donors!

Matthiesen family launches fundraising campaign for MPAN research

Matthiesen family launches fundraising campaign for MPAN research

On 29 November, the Saarländischer Rundfunk (SR) drew attention to the
situation of the family and their fundraising campaign in an empathetic way. Television report Attention.

Just the September before, the Matthiesen family had received the diagnosis of MPAN for their 12-year-old daughter Maya. They were dismayed to learn that the disease – like all forms of NBIA – is currently incurable and urgently needs further research. That's why she went public and, in cooperation with Hoffnungsbaum e.V. started to work with the help of a Crowdfundingwebsite to raise money for MPAN research. If you would like to donate to MPAN research, you can make your transfer to the well-known donation account of Hoffnungsbaum send. It is important that "MPAN" or "Maya" is indicated as the intended use.

MPAN (Mitochondrial Membrane Protein-Associated Neurodegeneration) is one of the four most common forms of the very rare group of NBIA diseases and, in addition to the characteristic iron deposits in the basal ganglia, inexorably leads to movement disorders and other symptoms that greatly impair life."

Subscribe to our Hoffnungsbaum newsletter!

With our newsletter e-mails you will receive valuable information about NBIA. If you would like to receive additional information on individual NBIA variants or special information for researchers/clinicians in addition to the general newsletter, please click here: Subscribe to additional information

Privacy policy

You have successfully registered!